表紙:ニコチン置換療法市場規模:製品タイプ、投与経路、方法、流通チャネル別、世界予測(2024年~2032年)
市場調査レポート
商品コード
1404041

ニコチン置換療法市場規模:製品タイプ、投与経路、方法、流通チャネル別、世界予測(2024年~2032年)

Nicotine Replacement Therapy Market Size - By Product Type (Gum, Transdermal Patch, Lozenges, Inhaler, Spray), Route of Administration (Oral, Transdermal, Nasal), Mode (OTC, Prescription), Distribution Channel, & Global Forecast, (2024 - 2032)

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 180 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニコチン置換療法市場規模:製品タイプ、投与経路、方法、流通チャネル別、世界予測(2024年~2032年)
出版日: 2023年12月21日
発行: Global Market Insights Inc.
ページ情報: 英文 180 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ニコチン置換療法の世界市場は、NRTを支援するFDAの積極的な対策により、2024年から2032年の間に8.2%のCAGRを示すと思われます。

FDAは、ガイドラインやイニシアチブを進化させながら、禁煙のためのより安全な代替手段を推進しています。こうした取り組みが市場を牽引し、NRT製品のイノベーションとアクセシビリティを促しています。

例えば、2023年5月、米国FDAの医薬品評価研究センター(CDER)は、禁煙を支援するニコチン置換療法(NRT)医薬品の開発においてスポンサーを支援する決定的なガイドラインを発表しました。同ガイドラインでは、その製品が承認された医薬品のジェネリック医薬品であるか、既存の医薬品と類似しているかによって、必要なデータが異なることを概説しています。ほとんどのスポンサーは、承認済み製品から得られた安全性と有効性の知見を活用し、簡略新薬承認申請(ANDA)や505(b)(2)のような経路で承認を追求すると予想されます。

規制当局のサポートが高まるにつれ、多様なNRTの選択肢に対する需要が急増します。これは、より健康的な生活習慣への消費者のシフトと、FDAの先進的な取り組みによって促進される効果的なニコチン置換療法への関心の高まりを反映しています。

ロゼンジ分野は2024年から2032年にかけて大きな発展を遂げると思われます。控えめで便利なニコチン送達を提供するこれらのロゼンジは、禁煙の効果的な助っ人として役立ちます。ユーザーフレンドリーな形態と管理された投与量により、喫煙に代わる選択肢を求める個人を対象としています。消費者が使いやすさを優先し、徐々にニコチンを減らしていくため、NRT市場におけるロゼンジの需要は急増し続けており、禁煙に向けた旅路において実用的で利用しやすいソリューションを好む傾向が強まっていることを反映しています。

ニコチン置換療法市場は、2024年から2032年にかけて小売薬局セグメントで顕著なCAGRを記録します。ヘルスケア製品の入手しやすく信頼できる拠点として、小売薬局はニコチンパッチ、ガム、トローチなどの禁煙補助剤を求める消費者に対応しています。これらの店舗は、利便性と信頼性の高いヘルスケアソリューションを求める消費者の嗜好に合わせて、ガイダンスと多様なNRTオプションを提供しています。小売薬局の需要が堅調であることは、NRT製品の供給と教育、アクセスの促進、禁煙に向けた喫煙者の支援において、小売薬局が極めて重要な役割を担っていることを裏付けています。

欧州のニコチン置換療法産業は、2024年から2032年にかけて顕著なCAGRを示すと思われます。公衆衛生への取り組みや禁煙プログラムに注目が集まる中、パッチ、ガム、トローチなどのNRT製品が勢いを増しています。欧州の消費者は、薬局やヘルスケアプロバイダーを通じて提供される、利用しやすく規制されたNRTの選択肢をますます求めるようになっています。禁煙が優先事項となるにつれ、この地域ではNRT補助剤の需要が急増しています。これは、より健康的なライフスタイルに向けた協調的な取り組みと、欧州の多様な人口集団の喫煙率を下げるための集団的な推進力を反映しています。

例えば、2023年9月の欧州呼吸器学会国際会議では、ニコチン代替ロゼンジとともにバレニクリンを使用した入院喫煙者の禁煙率が高いことが明らかになった。モナシュ大学のMichael J. Abramson博士は、バレニクリンと経口ニコチン補充剤を併用することで、禁煙の成功率が高まることを示唆しました。この併用療法は、報告された転帰において有効性を示し、忍容性も良好であったことから、入院患者の禁煙に有望なアプローチであることが示されました。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ニコチン置換療法市場の洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • 世界のがん患者の増加
      • 禁煙への取り組みの増加
      • 健康意識と教育の高まり
    • 業界の潜在的リスク&課題
      • 関連する副作用
      • 厳しい規制と制限
  • 成長可能性分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 ニコチン置換療法市場推計・予測:製品タイプ別、2018年~2032年

  • 主要動向:製品タイプ別
  • ガム
  • ロゼンジ
  • 経皮パッチ
  • 吸入剤
  • 鼻腔スプレー
  • 舌下錠

第6章 ニコチン置換療法市場推計・予測:投与経路別、2018年~2032年

  • 主要動向:投与経路別
  • 経口剤
  • 経皮
  • 経鼻

第7章 ニコチン置換療法市場推計・予測:モード別、2018年~2032年

  • 主要動向:モード別
  • 市販薬(OTC)
  • 処方薬

第8章 ニコチン置換療法市場推計・予測:流通チャネル別、2018年~2032年

  • 主要動向:流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 ニコチン置換療法市場推計・予測:地域別、2018年~2032年

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第10章 企業プロファイル

  • Pfizer, Inc.
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson
  • Cipla Ltd.
  • Fertin Pharma
  • Rubicon Research Pvt Ltd.
  • Sparsh Pharma
  • GlaxoSmithKline plc
  • Perrigo Company plc
  • Pierre Fabre Group
図表

Data Tables

  • TABLE 1 Market revenue, by product type (2023)
  • TABLE 2 Market revenue, route of administration (2023)
  • TABLE 3 Market revenue, by mode (2023)
  • TABLE 4 Market revenue, by distribution channel (2023)
  • TABLE 5 Market share, by region (2023)
  • TABLE 6 Global nicotine replacement therapy market size, by region, 2018 - 2023 (USD Million)
  • TABLE 7 Global nicotine replacement therapy market size, by region, 2024 - 2032 (USD Million)
  • TABLE 8 Global nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 9 Global nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 10 Global nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 11 Global nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 12 Global nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 13 Global nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 14 Global nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 15 Global nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Gums market, 2018 - 2023 (USD Million)
  • TABLE 18 Gums market, 2024 - 2032 (USD Million)
  • TABLE 19 Lozenges market, 2018 - 2023 (USD Million)
  • TABLE 20 Lozenges market, 2024 - 2032 (USD Million)
  • TABLE 21 Transdermal patches market, 2018 - 2023 (USD Million)
  • TABLE 22 Transdermal patches market, 2024 - 2032 (USD Million)
  • TABLE 23 Inhalers market, 2018 - 2023 (USD Million)
  • TABLE 24 Inhalers market, 2024 - 2032 (USD Million)
  • TABLE 25 Nasal sprays market, 2018 - 2023 (USD Million)
  • TABLE 26 Nasal sprays market, 2024 - 2032 (USD Million)
  • TABLE 27 Sublingual tablets market, 2018 - 2023 (USD Million)
  • TABLE 28 Sublingual tablets market, 2024 - 2032 (USD Million)
  • TABLE 29 Oral market, 2018 - 2023 (USD Million)
  • TABLE 30 Oral market, 2024 - 2032 (USD Million)
  • TABLE 31 Transdermal market, 2018 - 2023 (USD Million)
  • TABLE 32 Transdermal market, 2024 - 2032 (USD Million)
  • TABLE 33 Nasal market, 2018 - 2023 (USD Million)
  • TABLE 34 Nasal market, 2024 - 2032 (USD Million)
  • TABLE 35 Over the counter (OTC) market, 2018 - 2023 (USD Million)
  • TABLE 36 Over the counter (OTC) market, 2024 - 2032 (USD Million)
  • TABLE 37 Prescription market, 2018 - 2023 (USD Million)
  • TABLE 38 Prescription market, 2024 - 2032 (USD Million)
  • TABLE 39 Hospital pharmacy market, 2018 - 2023 (USD Million)
  • TABLE 40 Hospital pharmacy market, 2024 - 2032 (USD Million)
  • TABLE 41 Retail pharmacy market, 2018 - 2023 (USD Million)
  • TABLE 42 Retail pharmacy market, 2024 - 2032 (USD Million)
  • TABLE 43 Online pharmacy market, 2018 - 2023 (USD Million)
  • TABLE 44 Online pharmacy market, 2024 - 2032 (USD Million)
  • TABLE 45 North America nicotine replacement therapy market size, by country, 2018 - 2023 (USD Million)
  • TABLE 46 North America nicotine replacement therapy market size, by country, 2024 - 2032 (USD Million)
  • TABLE 47 North America nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 48 North America nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 49 North America nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 50 North America nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 51 North America nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 52 North America nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 53 North America nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 54 North America nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 55 U.S. nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 56 U.S. nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 57 U.S. nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 58 U.S. nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 59 U.S. nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 60 U.S. nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 61 U.S. nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 62 U.S. nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 63 Canada nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 64 Canada nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 65 Canada nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 66 Canada nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 67 Canada nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 68 Canada nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 69 Canada nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 70 Canada nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 71 Europe nicotine replacement therapy market size, by country, 2018 - 2023 (USD Million)
  • TABLE 72 Europe nicotine replacement therapy market size, by country, 2024 - 2032 (USD Million)
  • TABLE 73 Europe nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 74 Europe nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 75 Europe nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 76 Europe nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 77 Europe nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 78 Europe nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 79 Europe nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 80 Europe nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 81 Germany nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 82 Germany nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 83 Germany nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 84 Germany nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 85 Germany nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 86 Germany nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 87 Germany nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 88 Germany nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 89 UK nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 90 UK nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 91 UK nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 92 UK nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 93 UK nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 94 UK nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 95 UK nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 96 UK nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 97 France nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 98 France nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 99 France nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 100 France nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 101 France nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 102 France nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 103 France nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 104 France nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 105 Spain nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 106 Spain nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 107 Spain nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 108 Spain nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 109 Spain nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 110 Spain nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 111 Spain nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 112 Spain nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 113 Italy nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 114 Italy nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 115 Italy nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 116 Italy nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 117 Italy nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 118 Italy nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 119 Italy nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 120 Italy nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 121 Rest of Europe nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 122 Rest of Europe nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 123 Rest of Europe nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 124 Rest of Europe nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 125 Rest of Europe nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 126 Rest of Europe nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 127 Rest of Europe nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 128 Rest of Europe nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 129 Asia Pacific nicotine replacement therapy market size, by country, 2018 - 2023 (USD Million)
  • TABLE 130 Asia Pacific nicotine replacement therapy market size, by country, 2024 - 2032 (USD Million)
  • TABLE 131 Asia Pacific nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 132 Asia Pacific nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 133 Asia Pacific nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 134 Asia Pacific nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 135 Asia Pacific nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 136 Asia Pacific nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 137 Asia Pacific nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 138 Asia Pacific nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 139 China nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 140 China nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 141 China nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 142 China nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 143 China nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 144 China nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 145 China nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 146 China nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 147 Japan nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 148 Japan nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 149 Japan nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 150 Japan nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 151 Japan nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 152 Japan nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 153 Japan nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 154 Japan nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 155 India nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 156 India nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 157 India nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 158 India nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 159 India nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 160 India nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 161 India nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 162 India nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 163 Australia nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 164 Australia nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 165 Australia nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 166 Australia nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 167 Australia nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 168 Australia nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 169 Australia nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 170 Australia nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 171 Rest of Asia Pacific nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 172 Rest of Asia Pacific nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 173 Rest of Asia Pacific nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 174 Rest of Asia Pacific nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 175 Rest of Asia Pacific nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 176 Rest of Asia Pacific nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 177 Rest of Asia Pacific nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 178 Rest of Asia Pacific nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 179 Latin America nicotine replacement therapy market size, by country, 2018 - 2023 (USD Million)
  • TABLE 180 Latin America nicotine replacement therapy market size, by country, 2024 - 2032 (USD Million)
  • TABLE 181 Latin America nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 182 Latin America nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 183 Latin America nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 184 Latin America nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 185 Latin America nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 186 Latin America nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 187 Latin America nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 188 Latin America nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 189 Brazil nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 190 Brazil nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 191 Brazil nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 192 Brazil nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 193 Brazil nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 194 Brazil nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 195 Brazil nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 196 Brazil nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 197 Mexico nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 198 Mexico nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 199 Mexico nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 200 Mexico nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 201 Mexico nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 202 Mexico nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 203 Mexico nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 204 Mexico nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 205 Rest of Latin America nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 206 Rest of Latin America nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 207 Rest of Latin America nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 208 Rest of Latin America nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 209 Rest of Latin America nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 210 Rest of Latin America nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 211 Rest of Latin America nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 212 Rest of Latin America nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 213 Middle East & Africa nicotine replacement therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 214 Middle East & Africa nicotine replacement therapy market size, by country, 2024 - 2032 (USD Million)
  • TABLE 215 Middle East & Africa nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 216 Middle East & Africa nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 217 Middle East & Africa nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 218 Middle East & Africa nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 219 Middle East & Africa nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 220 Middle East & Africa nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 221 Middle East & Africa nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 222 Middle East & Africa nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 223 South Africa nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 224 South Africa nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 225 South Africa nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 226 South Africa nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 227 South Africa nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 228 South Africa nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 229 South Africa nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 230 South Africa nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 231 Saudi Arabia nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 232 Saudi Arabia nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 233 Saudi Arabia nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 234 Saudi Arabia nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 235 Saudi Arabia nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 236 Saudi Arabia nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 237 Saudi Arabia nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 238 Saudi Arabia nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 239 Rest of Middle East & Africa nicotine replacement therapy market size, by product type, 2018 - 2023 (USD Million)
  • TABLE 240 Rest of Middle East & Africa nicotine replacement therapy market size, by product type, 2024 - 2032 (USD Million)
  • TABLE 241 Rest of Middle East & Africa nicotine replacement therapy market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 242 Rest of Middle East & Africa nicotine replacement therapy market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 243 Rest of Middle East & Africa nicotine replacement therapy market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 244 Rest of Middle East & Africa nicotine replacement therapy market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 245 Rest of Middle East & Africa nicotine replacement therapy market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 246 Rest of Middle East & Africa nicotine replacement therapy market size, by distribution channel, 2024 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Nicotine replacement therapy market industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Industry landscape analysis, 2018 - 2032 (USD Million)
  • FIG 8 Growth potential analysis, by product type
  • FIG 9 Growth potential analysis, by route of administration
  • FIG 10 Growth potential analysis, by mode
  • FIG 11 Growth potential analysis, by distribution channel
  • FIG 12 Porter's analysis
  • FIG 13 PESTEL analysis
  • FIG 14 Company matrix analysis, 2023
  • FIG 15 Competitive analysis of major market players, 2023
  • FIG 16 Competitive positioning matrix, 2023
  • FIG 17 Strategic dashboard, 2023
目次
Product Code: 7725

Global Nicotine Replacement Therapy Market will witness 8.2% CAGR between 2024 and 2032 due to the FDA's proactive measures in aiding NRTs. With evolving guidelines and initiatives, the FDA promotes safer alternatives for smoking cessation. These efforts drive the market, encouraging innovation and accessibility in NRT products.

For instance, in May 2023, the US FDA's Center for Drug Evaluation and Research (CDER) released a definitive guideline aiding sponsors in developing nicotine replacement therapy (NRT) drug products to aid smoking cessation. The guidance outlined varying data requisites based on whether the product is a generic version of an approved drug or shares similarities with an existing one. Most sponsors are expected to pursue approval through pathways like the abbreviated new drug application (ANDA) or the 505(b)(2) route, leveraging the agency's safety and efficacy findings from approved products.

As regulatory support grows, there's a surge in demand for diverse NRT options, reflecting a consumer shift towards healthier habits and a heightened focus on effective nicotine replacement therapies facilitated by the FDA's progressive initiatives.

The overall Nicotine Replacement Therapy Market share is classified based on the product type, distribution channel, and region.

Lozenges segment will undergo significant development from 2024 to 2032. Offering discreet and convenient delivery of nicotine, these lozenges serve as an effective aid for smoking cessation. With their user-friendly format and controlled dosage, they cater to individuals seeking an alternative to smoking. As consumers prioritize ease of use and gradual nicotine reduction, the demand for lozenges within the NRT market continues to soar, reflecting a growing preference for practical and accessible solutions in the journey toward quitting smoking.

Nicotine replacement therapy market size from the retail pharmacy segment will register a noteworthy CAGR from 2024 to 2032. As accessible and trusted hubs for healthcare products, retail pharmacies cater to consumers seeking smoking cessation aids like nicotine patches, gums, and lozenges. These outlets provide guidance and diverse NRT options, aligning with consumer preferences for convenience and reliable healthcare solutions. The robust demand within retail pharmacies underscores their pivotal role in supplying and educating individuals on NRT products, facilitating access, and aiding smokers in their journey toward quitting.

Europe nicotine replacement therapy industry will showcase a commendable CAGR from 2024 to 2032. With a focus on public health initiatives and smoking cessation programs, NRT products like patches, gums, and lozenges gain momentum. European consumers increasingly seek accessible and regulated NRT options offered through pharmacies and healthcare providers. As smoking cessation becomes a priority, the region experiences an upsurge in demand for NRT aids, reflecting a concerted effort towards healthier lifestyles and a collective drive to reduce smoking prevalence across diverse European populations.

For instance, in September 2023, At the European Respiratory Society International Congress, findings revealed higher quit rates among hospitalized smokers who used varenicline alongside nicotine replacement lozenges. Michael J. Abramson, Ph.D., from Monash University, suggested that combining varenicline with oral nicotine replacement enhances cessation success. The combination therapy showed effectiveness in reported outcomes and was well-tolerated, indicating a promising approach for quitting smoking among hospitalized individuals.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Nicotine replacement therapy industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Product type trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Mode trends
    • 2.1.6 Distribution channel trends

Chapter 3 Nicotine Replacement Therapy Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing cases of cancer globally
      • 3.2.1.2 Increasing smoking cessation initiatives
      • 3.2.1.3 Rising health awareness & education
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Associated side effects
      • 3.2.2.2 Stringent regulations and restrictions
  • 3.3 Growth potential analysis
    • 3.3.1 By product type
    • 3.3.2 By route of administration
    • 3.3.3 By mode
    • 3.3.4 By distribution channel
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2023
  • 4.3 Competitive analysis of major market players, 2023
  • 4.4 Competitive positioning matrix, 2023
  • 4.5 Strategic dashboard, 2023

Chapter 5 Nicotine Replacement Therapy Market Estimates and Forecast, By Product Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by product type
  • 5.2 Gums
  • 5.3 Lozenges
  • 5.4 Transdermal patches
  • 5.5 Inhalers
  • 5.6 Nasal sprays
  • 5.7 Sublingual tablets

Chapter 6 Nicotine Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Oral
  • 6.3 Transdermal
  • 6.4 Nasal

Chapter 7 Nicotine Replacement Therapy Market Estimates and Forecast, By Mode, 2018-2032 (USD Million)

  • 7.1 Key trends, by mode
  • 7.2 Over the counter (OTC)
  • 7.3 Prescription

Chapter 8 Nicotine Replacement Therapy Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Nicotine Replacement Therapy Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Pfizer, Inc.
  • 10.2 Glenmark Pharmaceuticals Limited
  • 10.3 Johnson & Johnson
  • 10.4 Cipla Ltd.
  • 10.5 Fertin Pharma
  • 10.6 Rubicon Research Pvt Ltd.
  • 10.7 Sparsh Pharma
  • 10.8 GlaxoSmithKline plc
  • 10.9 Perrigo Company plc
  • 10.10 Pierre Fabre Group